Reviewing Universal American (UAM) & Magellan Health (MGLN)
Universal American (NYSE: UAM) and Magellan Health (NASDAQ:MGLN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.
Valuation and Earnings
This table compares Universal American and Magellan Health’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Magellan Health||$5.28 billion||0.35||$242.58 million||$3.53||22.14|
Magellan Health has higher revenue and earnings than Universal American. Universal American is trading at a lower price-to-earnings ratio than Magellan Health, indicating that it is currently the more affordable of the two stocks.
This table compares Universal American and Magellan Health’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Volatility & Risk
Universal American has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Comparatively, Magellan Health has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500.
Insider & Institutional Ownership
85.7% of Universal American shares are owned by institutional investors. Comparatively, 93.5% of Magellan Health shares are owned by institutional investors. 7.7% of Universal American shares are owned by insiders. Comparatively, 3.6% of Magellan Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This is a breakdown of recent recommendations for Universal American and Magellan Health, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Universal American currently has a consensus target price of $10.00, indicating a potential upside of 0.30%. Magellan Health has a consensus target price of $80.25, indicating a potential upside of 2.69%. Given Magellan Health’s stronger consensus rating and higher possible upside, analysts plainly believe Magellan Health is more favorable than Universal American.
Magellan Health beats Universal American on 9 of the 11 factors compared between the two stocks.
Universal American Company Profile
Universal American Corp. provides an array of health insurance and managed care products and services to people covered by Medicare. The Company’s segments include Medicare Advantage, Management Services Organization (MSO), and Corporate & Other. The Medicare Advantage segment contains the operations of its initiatives in managed care for seniors. It operated 16 Medicare Shared Saving Program Accountable Care Organizations (ACOs) and two Next Generation ACOs, which included approximately 5,200 participating providers with approximately 221,800 assigned Medicare fee-for-service beneficiaries, as of December 31, 2016. The MSO segment supports its physician partnerships in the development of healthcare models, such as ACOs, with a range of capabilities and resources, including technology, analytics, clinical care coordination, regulatory compliance and program administration. It has developed a primary care physician alignment strategy, which is branded as The Healthy Collaboration.
Magellan Health Company Profile
Magellan Health, Inc. is engaged in the healthcare management business. The Company’s segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).
Receive News & Ratings for Universal American Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal American Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.